FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Grants Fast Track for S. Aureus Infection Therapy

[ Price : $8.95]

FDA grants fast track designation to Xbiotech for its monoclonal antibody therapy for treating all forms of Staphylococcus aureus ...

FDA Clears EarLens Contact Hearing Aid

[ Price : $8.95]

FDA clears an EarLens Corp. de novo petition for the EarLens Contact Hearing Device, a new hearing aid that uses a laser diode and...

Court Nixes DEA Scheduling Argument

[ Price : $8.95]

The DC federal court says that Eisai is not entitled to an extension of its marketing exclusivity for two drugs whose market entry...

Stakeholders Comment on Cyclosporine Letter

[ Price : $8.95]

Allergan says FDA should not think it can be talking with ANDA first applicants for generic Restasis because no generic drug compa...

Harmonized Benefit/Risk Info Guidance

[ Price : $8.95]

FDA publishes a draft International Conference on Harmonization guidance on enhancing the format and structure of benefit-risk inf...

Issues Raised with FDA PDUFA Meeting Guidance

[ Price : $8.95]

BIO says an FDA draft guidance on formal meetings between the agency and sponsors of PDUFA products will give additional clarity.

Dissolution Testing Guidance Welcome

[ Price : $8.95]

Companies welcome an FDA guidance on dissolution testing and raise additional concerns.

FDA Centers Give Updates on Promotion Violations

[ Price : $8.95]

Presentations by CDER, CBER and CDRH advertising and promotion officials discuss current issues and violations observed at the age...

Justice Department Focusing on Individual Accountability: Official

[ Price : $8.95]

Justice Department Consumer Protection Branch assistant director Jill Furman says individual accountability for corporate wrongdoi...

FDA Approves BMS Opdivo/Yervoy for Melanoma

[ Price : $8.95]

FDA approves a Bristol-Myers Squibb NDA for Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for treating patients with ...